Octapharma is the world's largest privately-owned, independent company specializing in the field of blood plasma fractionation. With over 11,000 employees, we lead in the development and production of essential human proteins derived from human plasma and human cell lines. We support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Hematology, and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centers across Europe and the US. Out sites in Germany: 📍 Octapharma Produktionsgesellschaft Deutschland mbH, Springe 📍 Octapharma Dessau GmbH, Dessau 📍 Octapharma Biopharmaceuticals GmbH, Heidelberg, Frankfurt, Berlin 📍 Octapharma GmbH, Langenfeld 📍 Octapharma Plasma GmbH, Langenfeld Community guidelines: https://bit.ly/3M8ioml